IL136667A0 - Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system - Google Patents
Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression systemInfo
- Publication number
- IL136667A0 IL136667A0 IL13666798A IL13666798A IL136667A0 IL 136667 A0 IL136667 A0 IL 136667A0 IL 13666798 A IL13666798 A IL 13666798A IL 13666798 A IL13666798 A IL 13666798A IL 136667 A0 IL136667 A0 IL 136667A0
- Authority
- IL
- Israel
- Prior art keywords
- expression system
- yeast expression
- restin
- endostatin
- methods
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102400000068 Angiostatin Human genes 0.000 title abstract 2
- 108010079709 Angiostatins Proteins 0.000 title abstract 2
- 102400001047 Endostatin Human genes 0.000 title abstract 2
- 108010079505 Endostatins Proteins 0.000 title abstract 2
- 241000235648 Pichia Species 0.000 title abstract 2
- 102400001051 Restin Human genes 0.000 title abstract 2
- 230000001772 anti-angiogenic effect Effects 0.000 title abstract 2
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 title abstract 2
- 108010038764 cytoplasmic linker protein 170 Proteins 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6788897P | 1997-12-08 | 1997-12-08 | |
US8266398P | 1998-04-22 | 1998-04-22 | |
US10853698P | 1998-11-16 | 1998-11-16 | |
PCT/US1998/025892 WO1999029878A2 (en) | 1997-12-08 | 1998-12-08 | Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
Publications (1)
Publication Number | Publication Date |
---|---|
IL136667A0 true IL136667A0 (en) | 2001-06-14 |
Family
ID=27371250
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13666798A IL136667A0 (en) | 1997-12-08 | 1998-12-08 | Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
IL13666598A IL136665A0 (en) | 1997-12-08 | 1998-12-08 | Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
IL13666898A IL136668A0 (en) | 1997-12-08 | 1998-12-08 | Restin and methods of use thereof |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13666598A IL136665A0 (en) | 1997-12-08 | 1998-12-08 | Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
IL13666898A IL136668A0 (en) | 1997-12-08 | 1998-12-08 | Restin and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
EP (3) | EP1037983A1 (xx) |
JP (3) | JP2002503449A (xx) |
KR (3) | KR20010015867A (xx) |
CN (3) | CN1284134A (xx) |
AT (1) | ATE319840T1 (xx) |
AU (3) | AU749904B2 (xx) |
CA (3) | CA2313705A1 (xx) |
DE (1) | DE69833794D1 (xx) |
IL (3) | IL136667A0 (xx) |
WO (3) | WO1999029855A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797488B1 (en) | 1997-12-08 | 2004-09-28 | Beth Israel Deaconess Medical Center | Methods of producing anti-angiogenic proteins |
US6852691B1 (en) | 1997-12-08 | 2005-02-08 | Beth Israel Deaconess Medical Center | Anti-angiogenic peptides and methods of use thereof |
KR20010015867A (ko) * | 1997-12-08 | 2001-02-26 | 베쓰 이스라엘 디코니스 메디칼 센터 | 항-혈관형성 활성을 지니고 있는, 엔도스타틴의 변이체인"em 1" 및 이것을 사용하는 방법 |
WO2000017240A1 (de) * | 1998-09-21 | 2000-03-30 | Haemopep Pharma Gmbh | Hmw-endostatin zur hemmung des wachstums von tumoren und von gefässwucherungen und zur diagnose von gefäss- und tumorerkrankungen |
IT1312077B1 (it) * | 1999-04-15 | 2002-04-04 | Univ Degli Studi Milano | Polipeptidi ad attivita' antiangiogenica. |
JP2001031586A (ja) * | 1999-07-14 | 2001-02-06 | Sunstar Inc | 動脈硬化症及び動脈硬化症に起因する疾患の予防又は治療組成物 |
FR2803207B1 (fr) * | 1999-12-30 | 2004-04-30 | Aventis Pharma Sa | Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes |
ATE303820T1 (de) * | 1999-12-30 | 2005-09-15 | Aventis Pharma Sa | Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut |
EP1171602A1 (en) * | 2000-02-10 | 2002-01-16 | ZymoGenetics, Inc. | Anti-angiogenic intestinal peptides, zdint5 |
CN1311228A (zh) * | 2000-03-02 | 2001-09-05 | 上海博德基因开发有限公司 | 一种新的多肽——人精子特异蛋白em1,em6-48和编码这种多肽的多核苷酸 |
EP1666595A1 (en) | 2000-10-26 | 2006-06-07 | Beth Israel Deaconess Medical Center, Inc. | GAB2 (P97) gene and methods of use thereof |
KR100579660B1 (ko) * | 2003-08-18 | 2006-05-15 | 정인식 | 제미니바이러스 발현시스템을 이용한 재조합 신생혈관생성억제 단백질의 제조방법 |
US7524811B2 (en) | 2003-08-29 | 2009-04-28 | Children's Medical Center Corporation | Anti-angiogenic peptides from the N-terminus of endostatin |
JP2007529410A (ja) * | 2003-08-29 | 2007-10-25 | チルドレンズ メディカル センター コーポレーション | 子宮内膜症を治療又は防止するためのペプチド |
ES2325344B1 (es) * | 2004-11-02 | 2010-06-09 | Univ Madrid Autonoma | Inhibidores de angiogenesis multifuncionales y multivalentes. |
US8586544B2 (en) | 2008-04-04 | 2013-11-19 | Procell Therapeutics Inc. | Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
AU2012306826B2 (en) * | 2011-09-09 | 2018-01-04 | Beijing Protgen Ltd. | Endostatin mutants with mutations at ATP binding sites |
EP2628748A1 (en) | 2012-02-14 | 2013-08-21 | Szilak Laboratories Bioinformatics & Molecule-Design Ltd. | Angiostatin chimeras and uses thereof |
CN104926933B (zh) * | 2014-03-19 | 2018-09-07 | 北京仁和天通生物科技有限公司 | Endostatin突变体、Endostatin突变体与聚乙二醇的交联物以及它们的应用 |
CN107849117B (zh) | 2015-06-05 | 2022-08-26 | 艾比欧公司 | 用于治疗纤维化的内皮抑素片段和变体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0758390B1 (en) * | 1994-04-26 | 2007-02-28 | The Children's Medical Center Corporation | Angiostatin and method of use for inhibition of angiogenesis |
US5945403A (en) * | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
CZ334097A3 (cs) * | 1995-04-26 | 1998-04-15 | The Children's Medical Center Corporation | Fragmenty angiostatinu, agregovaný angiostatin a způsoby jeho použití |
DE69629826T2 (de) * | 1995-10-23 | 2004-07-01 | Children's Medical Center Corp., Boston | Therapeutische antiangiogenische zusammensetzungen und verfahren |
EP1019515A1 (en) * | 1997-10-01 | 2000-07-19 | G.D. SEARLE & CO. | Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
WO1999026480A1 (en) * | 1997-11-20 | 1999-06-03 | Genetix Pharmaceuticals, Inc. | Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases |
KR20010015867A (ko) * | 1997-12-08 | 2001-02-26 | 베쓰 이스라엘 디코니스 메디칼 센터 | 항-혈관형성 활성을 지니고 있는, 엔도스타틴의 변이체인"em 1" 및 이것을 사용하는 방법 |
-
1998
- 1998-12-08 KR KR1020007006248A patent/KR20010015867A/ko not_active Application Discontinuation
- 1998-12-08 JP JP2000524427A patent/JP2002503449A/ja active Pending
- 1998-12-08 WO PCT/US1998/026057 patent/WO1999029855A1/en not_active Application Discontinuation
- 1998-12-08 AU AU18088/99A patent/AU749904B2/en not_active Ceased
- 1998-12-08 EP EP98962006A patent/EP1037983A1/en not_active Withdrawn
- 1998-12-08 JP JP2000524449A patent/JP2001526040A/ja active Pending
- 1998-12-08 EP EP98962932A patent/EP1038011B1/en not_active Expired - Lifetime
- 1998-12-08 AT AT98962932T patent/ATE319840T1/de not_active IP Right Cessation
- 1998-12-08 IL IL13666798A patent/IL136667A0/xx unknown
- 1998-12-08 EP EP98962966A patent/EP1037985A1/en not_active Withdrawn
- 1998-12-08 WO PCT/US1998/025892 patent/WO1999029878A2/en active IP Right Grant
- 1998-12-08 KR KR1020007006250A patent/KR20010015869A/ko not_active Application Discontinuation
- 1998-12-08 CA CA002313705A patent/CA2313705A1/en not_active Abandoned
- 1998-12-08 CA CA002312287A patent/CA2312287A1/en not_active Abandoned
- 1998-12-08 IL IL13666598A patent/IL136665A0/xx unknown
- 1998-12-08 CN CN98811934A patent/CN1284134A/zh active Pending
- 1998-12-08 CA CA002313251A patent/CA2313251A1/en not_active Abandoned
- 1998-12-08 JP JP2000524428A patent/JP2001526031A/ja active Pending
- 1998-12-08 IL IL13666898A patent/IL136668A0/xx unknown
- 1998-12-08 CN CN98811953A patent/CN1284130A/zh active Pending
- 1998-12-08 DE DE69833794T patent/DE69833794D1/de not_active Expired - Lifetime
- 1998-12-08 AU AU18065/99A patent/AU753889B2/en not_active Ceased
- 1998-12-08 AU AU17180/99A patent/AU742866B2/en not_active Ceased
- 1998-12-08 KR KR1020007006249A patent/KR20010015868A/ko not_active Application Discontinuation
- 1998-12-08 CN CN98811932A patent/CN1322246A/zh active Pending
- 1998-12-08 WO PCT/US1998/026058 patent/WO1999029856A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1038011B1 (en) | 2006-03-08 |
KR20010015868A (ko) | 2001-02-26 |
CA2313251A1 (en) | 1999-06-17 |
AU753889B2 (en) | 2002-10-31 |
AU1806599A (en) | 1999-06-28 |
WO1999029855A1 (en) | 1999-06-17 |
AU749904B2 (en) | 2002-07-04 |
KR20010015869A (ko) | 2001-02-26 |
ATE319840T1 (de) | 2006-03-15 |
AU1808899A (en) | 1999-06-28 |
AU1718099A (en) | 1999-06-28 |
JP2002503449A (ja) | 2002-02-05 |
IL136665A0 (en) | 2001-06-14 |
CN1284130A (zh) | 2001-02-14 |
CA2313705A1 (en) | 1999-06-17 |
WO1999029856A1 (en) | 1999-06-17 |
EP1037983A1 (en) | 2000-09-27 |
JP2001526040A (ja) | 2001-12-18 |
WO1999029878A3 (en) | 1999-09-16 |
WO1999029878A2 (en) | 1999-06-17 |
CN1322246A (zh) | 2001-11-14 |
DE69833794D1 (de) | 2006-05-04 |
CN1284134A (zh) | 2001-02-14 |
EP1037985A1 (en) | 2000-09-27 |
JP2001526031A (ja) | 2001-12-18 |
KR20010015867A (ko) | 2001-02-26 |
AU742866B2 (en) | 2002-01-17 |
CA2312287A1 (en) | 1999-06-17 |
EP1038011A2 (en) | 2000-09-27 |
IL136668A0 (en) | 2001-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL136667A0 (en) | Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system | |
ZA9710516B (en) | Process for the production of recombinant viruses. | |
NZ313625A (en) | Process for stabilizing proteins in an acidic environment with a high-ester pectin | |
DK1204738T3 (da) | Fremgangsmåde til nedsættelse af skumdannelsen under dyrkning af en mikroorganisme | |
ES2149268T3 (es) | Procedimiento de estabilizacion de bebidas. | |
WO1996022308A3 (en) | Appetite suppression factor and related methods | |
IL130190A0 (en) | Methods and compositions for polypeptide engineering | |
DE69534778D1 (en) | Cathepsin-02-protease | |
DK0894126T3 (da) | Alkalisk phosphatase-deficient trådformet svamp | |
EP0833912A4 (en) | NEW TRANSFORMING GROWTH FACTOR TYPE CYTOKINE TGF-BETA | |
AU9574198A (en) | Method of affinity cross-linking biologically active, immunogenic peptides to antibodies | |
WO1999021976A3 (en) | Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins | |
AR001732A1 (es) | Celulasa alcalina novedosa y método para producirla | |
AU1952497A (en) | Novel antibody-cytokine fusion protein, and methods of making and using the same | |
ATE292686T1 (de) | Herstellung von nisin-varianten | |
AU1719497A (en) | An enzyme with pectin esterase activity | |
AU6509898A (en) | Activation of peptides | |
AU6832094A (en) | Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections | |
NZ334744A (en) | Method for determining expression of aberrant forms of APC protein | |
WO2004089973A3 (en) | Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production | |
WO1998030687A3 (de) | Srcr domäne-enthaltendes protein | |
WO1999002659A3 (en) | Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase | |
WO1999036440A3 (en) | Expression of fusion proteins | |
WO1998024894A3 (de) | Pkd1-fragmente mit bindungsregionen für pkd1-spezifische antikörper | |
WO1999060152A8 (en) | Process for sialylating glycoproteins |